These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 21151479)

  • 61. [Standard technical specifications for methacholine chloride (Methacholine) bronchial challenge test (2023)].
    ; ;
    Zhonghua Jie He He Hu Xi Za Zhi; 2024 Feb; 47(2):101-119. PubMed ID: 38309959
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Knowledge and beliefs regarding cervical cancer screening and HPV vaccination among urban and rural women in León, Nicaragua.
    Rees HD; Lombardo AR; Tangoren CG; Meyers SJ; Muppala VR; Niccolai LM
    PeerJ; 2017; 5():e3871. PubMed ID: 29085745
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Barriers to HPV self-sampling and cytology among low-income indigenous women in rural areas of a middle-income setting: a qualitative study.
    Allen-Leigh B; Uribe-Zúñiga P; León-Maldonado L; Brown BJ; Lörincz A; Salmeron J; Lazcano-Ponce E
    BMC Cancer; 2017 Nov; 17(1):734. PubMed ID: 29121873
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Competing needs: a qualitative study of cervical cancer screening attendance among HPV-positive women in Tanzania.
    Linde DS; Rasch V; Mwaiselage JD; Gammeltoft TM
    BMJ Open; 2019 Feb; 9(2):e024011. PubMed ID: 30819704
    [TBL] [Abstract][Full Text] [Related]  

  • 66. "I'm neither here, which would be bad, nor there, which would be good": the information needs of HPV+ women. A qualitative study based on in-depth interviews and counselling sessions in Jujuy, Argentina.
    Szwarc L; Sánchez Antelo V; Paolino M; Arrossi S
    Sex Reprod Health Matters; 2021 Dec; 29(1):1991101. PubMed ID: 34779742
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The experience of adults who choose watchful waiting or active surveillance as an approach to medical treatment: a qualitative systematic review.
    Rittenmeyer L; Huffman D; Alagna M; Moore E
    JBI Database System Rev Implement Rep; 2016 Feb; 14(2):174-255. PubMed ID: 27536798
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Assessing the role of education in women's knowledge and acceptance of adjunct high-risk human Papillomavirus testing for cervical cancer screening.
    Papa D; Moore Simas TA; Reynolds M; Melnitsky H
    J Low Genit Tract Dis; 2009 Apr; 13(2):66-71. PubMed ID: 19387125
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Health technology assessment report: HPV DNA based primary screening for cervical cancer precursors].
    Ronco G; Biggeri A; Confortini M; Naldoni C; Segnan N; Sideri M; Zappa M; Zorzi M; Calvia M; Accetta G; Giordano L; Cogo C; Carozzi F; Gillio Tos A; Arbyn M; Mejier CJ; Snijders PJ; Cuzick J; Giorgi Rossi P
    Epidemiol Prev; 2012; 36(3-4 Suppl 1):e1-72. PubMed ID: 22828243
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Non-16/18 high-risk HPV infection predicts disease persistence and progression in women with an initial interpretation of LSIL.
    Lyons YA; Kamat AA; Zhou H; Mody DR; Schwartz MR; Hobday C; Ge Y
    Cancer Cytopathol; 2015 Jul; 123(7):435-42. PubMed ID: 25903015
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Pasifika women's knowledge and perceptions of cervical-cancer screening and the implementation of self-testing in Aotearoa New Zealand: A qualitative study.
    Brewer N; Foliaki S; Gray M; Potter JD; Douwes J
    Lancet Reg Health West Pac; 2022 Nov; 28():100551. PubMed ID: 35991536
    [TBL] [Abstract][Full Text] [Related]  

  • 72. HPV testing compared with routine cytology in cervical screening: long-term follow-up of ARTISTIC RCT.
    Gilham C; Sargent A; Kitchener HC; Peto J
    Health Technol Assess; 2019 Jun; 23(28):1-44. PubMed ID: 31219027
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Immediate referral to colposcopy versus cytological surveillance for minor cervical cytological abnormalities in the absence of HPV test.
    Kyrgiou M; Kalliala IE; Mitra A; Fotopoulou C; Ghaem-Maghami S; Martin-Hirsch PP; Cruickshank M; Arbyn M; Paraskevaidis E
    Cochrane Database Syst Rev; 2017 Jan; 1(1):CD009836. PubMed ID: 28125861
    [TBL] [Abstract][Full Text] [Related]  

  • 74. What questions do people ask on a human papillomavirus website? A comparative analysis of public and private questions.
    Lee SJ; Yun HJ; Lee KH; Kim CJ; Park JS
    Int J Med Sci; 2012; 9(2):142-7. PubMed ID: 22253561
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Women's triage and management preferences for cervical cytologic reports demonstrating atypical squamous cells of undetermined significance and low-grade squamous intraepithelial lesions.
    Ferris DG; Kriegel D; Cote L; Litaker M; Woodward L
    Arch Fam Med; 1997; 6(4):348-53. PubMed ID: 9225706
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Optimising follow-up strategy based on cytology and human papillomavirus after fertility-sparing surgery for early stage cervical cancer: a nationwide, population-based, retrospective cohort study.
    Schuurman TN; Schaafsma M; To KH; Verhoef VMJ; Sikorska K; Siebers AG; Wenzel HHB; Bleeker MCG; Roes EM; Zweemer RP; de Vos van Steenwijk PJ; Yigit R; Beltman JJ; Zusterzeel PLM; Lok CAR; Bekkers RLM; Mom CH; van Trommel NE
    Lancet Oncol; 2023 Dec; 24(12):1349-1358. PubMed ID: 37952541
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Young women, cervical intraepithelial neoplasia and human papillomavirus: risk factors for persistence and recurrence.
    Frega A; Stentella P; De Ioris A; Piazze JJ; Fambrini M; Marchionni M; Cosmi EV
    Cancer Lett; 2003 Jul; 196(2):127-34. PubMed ID: 12860270
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Perspectives of women participating in a cervical cancer screening campaign with community-based HPV self-sampling in rural western Kenya: a qualitative study.
    Oketch SY; Kwena Z; Choi Y; Adewumi K; Moghadassi M; Bukusi EA; Huchko MJ
    BMC Womens Health; 2019 Jun; 19(1):75. PubMed ID: 31196175
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds.
    C Kitchener H; Canfell K; Gilham C; Sargent A; Roberts C; Desai M; Peto J
    Health Technol Assess; 2014 Apr; 18(23):1-196. PubMed ID: 24762804
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Are women ready for the new cervical screening protocol in England? A systematic review and qualitative synthesis of views about human papillomavirus testing.
    Hendry M; Pasterfield D; Lewis R; Clements A; Damery S; Neal RD; Adke R; Weller D; Campbell C; Patnick J; Sasieni P; Hurt C; Wilson S; Wilkinson C
    Br J Cancer; 2012 Jul; 107(2):243-54. PubMed ID: 22699825
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.